Literature DB >> 6299078

Platelet-activating factor (PAF-acether), an activator of neutrophil functions.

E Jouvin-Marche, B Poitevin, J Benveniste.   

Abstract

The effect of totally synthetic PAF-acether (1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine), 2-lyso PAF-acether (1-O-octadecyl-sn-glyceryl-3-phosphorylcholine) and lyso-phosphatidylcholine on enzyme release and superoxide production from human polymorphonuclear neutrophils (PMN were studied. PMN (2 X 10(6) ml-1) were incubated at 37 degrees C with various concentrations of phospholipids in the absence of cytochalasin B. At 10(-7) M, PAF-acether induced superoxide production and beta-glucuronidase, acid phosphatase and lysosyme release, but not that of cytoplasmic lactic dehydrogenase. In the same condition 2-lyso PAF-acether and lyso-phosphatidylcholine were ineffective. In the presence of phagocytic stimuli PAF-acether enhanced in the range from 10(-7) M to 10(-10) M the enzyme release and only at 10(-7) M the superoxide production. Thus, the capacity of PAF-acether to stimulate PMN, as well as platelet function, indicates a prominent role for this lipid mediator in inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6299078     DOI: 10.1007/bf01965090

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  21 in total

1.  The role of platelet-activating factor in platelet aggregation.

Authors:  M Chignard; J P Le Couedic; M Tence; B B Vargaftig; J Benveniste
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

2.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent.

Authors:  B M Babior; R S Kipnes; J T Curnutte
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

3.  Release of platelet-activating factor (PAF-acether) from alveolar macrophages by the calcium ionophore A23187 and phagocytosis.

Authors:  B Arnoux; D Duval; J Benveniste
Journal:  Eur J Clin Invest       Date:  1980-12       Impact factor: 4.686

4.  Effect of synthetic PAF-acether on human neutrophil function.

Authors:  B M Czarnetzki; J Benveniste
Journal:  Agents Actions       Date:  1981-12

5.  Stereospecific activity of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine and comparison of analogs in the degranulation of platelets and neutrophils.

Authors:  R L Wykle; C H Miller; J C Lewis; J D Schmitt; J A Smith; J R Surles; C Piantadosi; J T O'Flaherty
Journal:  Biochem Biophys Res Commun       Date:  1981-06       Impact factor: 3.575

6.  Novel effects of 1-O-hexadecyl-2-acyl-sn-glycero-3-phosphorycholine mediators on human leukocyte function: delineation of the specific roles of the acyl substituents.

Authors:  E J Goetzl; C K Derian; A I Tauber; F H Valone
Journal:  Biochem Biophys Res Commun       Date:  1980-06-16       Impact factor: 3.575

7.  Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators).

Authors:  C A Demopoulos; R N Pinckard; D J Hanahan
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

8.  Mediators of immune-complex-induced aggregation of polymorphonuclear neutrophils. II. Platelet-activating factor as the effector substance of immune-induced aggregation.

Authors:  G Camussi; C Tetta; F Bussolino; F Caligaris Cappio; R Coda; C Masera; G Segoloni
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

9.  Enzyme release and superoxide anion production by human alveolar macrophages stimulated with immunoglobulin E.

Authors:  M Joseph; A B Tonnel; A Capron; C Voisin
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

10.  Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes.

Authors:  J M Mencia-Huerta; J Benveniste
Journal:  Eur J Immunol       Date:  1979-05       Impact factor: 5.532

View more
  4 in total

Review 1.  Cellular and humoral mediators of pulmonary edema.

Authors:  A B Malik; W M Selig; K E Burhop
Journal:  Lung       Date:  1985       Impact factor: 2.584

2.  Pathophysiological mechanisms of sudden death induced by platelet activating factor.

Authors:  A M Lefer; H F Müller; J B Smith
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

3.  Rapid and sensitive detection of hydroxyl radicals formed by activated neutrophils in the presence of chelated iron: hydroxylation of deoxyguanosine to 8-hydroxydeoxyguanosine.

Authors:  P Leanderson; C Tagesson
Journal:  Agents Actions       Date:  1992-05

4.  Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC).

Authors:  C E Sigal; F H Valone; M J Holtzman; E J Goetzl
Journal:  J Clin Immunol       Date:  1987-03       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.